Interleukin-9.
Renauld
J C
JC
Unit of Experimental Medicine, Université Catholique de Louvain, Brussels, Belgium.
Houssiau
F
F
Druez
C
C
Uyttenhove
C
C
Vink
A
A
Van Snick
J
J
D000595:Amino Acid Sequence; D000818:Animals; D003001:Cloning, Molecular; D005796:Genes; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D016906:Interleukin-9 / Q000235:genetics / Q000494:pharmacology / Q000502:physiology* / Q000633:toxicity; D016131:Lymphocyte Subsets / Q000187:drug effects; D016399:Lymphoma, T-Cell / Q000209:etiology; D008407:Mast Cells / Q000187:drug effects; D051379:Mice; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D011971:Receptors, Immunologic / Q000378:metabolism; D018123:Receptors, Interleukin; D053651:Receptors, Interleukin-9; D011993:Recombinant Fusion Proteins / Q000235:genetics; D013045:Species Specificity; D013953:Thymus Neoplasms / Q000209:etiology
C508045:IL9R protein, human; D016906:Interleukin-9; D011971:Receptors, Immunologic; D018123:Receptors, Interleukin; D053651:Receptors, Interleukin-9; D011993:Recombinant Fusion Proteins